In relation to a farm-in, I believe that is deferred post MK-2.
Some observations.
1. Recent CR is good for MK-2, 2D seismic, misc and working capital... but no more
2. 2D seismic will help mature leads in the east.
3. MK-2 will help declare a discovery, and also further prove the potential of the Mukuyu structure.
4. Post MK-2 and 2D seismic, IVZ will be in a position to update the Prospective Resource for the Block.
- Original Prospective Resource was based upon a lot of guess work from surface outcrops. MK-1 & MK-2 will provide a lot of useful data.
- A revised Prospective Resource will likely have a tighter control.
- The current Mukuyu Prospective Resource is <1TCF to >20TCF with a mean of 4TCF (Pebbly and below only)
- Very difficult for a farm-in partner to fully value the potential.
5. IVZ have now twice passed up the opportunity to farm-in pre-spud and have indicated that a junior partner would not have the capacity to develop the field and are looking for a partner with the capacity to develop the field.
6. For reference about deferred developments which the current board have experience with.... Uganda | Tullow Oil plc (LSE: TLW)
7. To accelerate development will require a major investment, from a major oil company. This field will require billions of dollars of "equity" investment.
8. The drilling of MK-2 and the new seismic is prettying up IVZ for a possible sale or farm-in from a major.
9. If the up-and-coming Zimbabwe elections go off without too many problems, it reduces the geographical risk, and puts the lipstick on any deal.
10. In any major farm-in it is likely that IVZ will take a minority stake as well as the existing partners will be diluted as well.
- Forums
- ASX - By Stock
- IVZ
- Ann: 2D Seismic commences at the Cabora Bassa Project
Ann: 2D Seismic commences at the Cabora Bassa Project, page-48
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IVZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.0¢ |
Change
-0.001(1.41%) |
Mkt cap ! $106.1M |
Open | High | Low | Value | Volume |
7.4¢ | 7.4¢ | 7.0¢ | $61.40K | 862.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 175629 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 7976 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 175629 | 0.070 |
2 | 102934 | 0.069 |
4 | 349117 | 0.068 |
4 | 214984 | 0.067 |
3 | 310000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 7976 | 1 |
0.073 | 232490 | 2 |
0.074 | 620738 | 5 |
0.075 | 743787 | 2 |
0.076 | 892581 | 5 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
IVZ (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online